You don't have to become a peptide expert
How referral-based peptide care works, and which parts of it stay with Baseline rather than with your practice.
Key takeaways
- A referral model keeps the patient relationship with your practice and moves the operational weight to Baseline.
- No formulary to learn, no compounding pharmacy accounts to open, no dosing decisions on your desk.
- Prescribing is handled by a licensed provider network.
- You keep visibility into what your patient was reviewed for and when they are due for review.
Most practices that get asked about peptides are being asked by good patients, not by people chasing a trend. The question is rarely whether the interest is real. It is whether the practice has time to build the knowledge, the prescribing pathway, and the pharmacy relationships behind it.
A referral model answers that differently. You keep the relationship and the primary care. Baseline handles intake, education, protocol coordination, and the follow-up cadence, with prescribing done by a licensed provider network.
That means no new formulary to learn, no compounding pharmacy accounts to open, and no dosing decisions landing on your desk at the end of a full clinic day.
What you do keep is visibility. You know what your patient was reviewed for, what they were placed on, and when they are due for a check-in.
The real barrier is time, not interest
Practices are asked about peptides by patients who are already engaged in their own health. Turning that interest into a service line means building knowledge, a prescribing pathway, pharmacy relationships, and a follow-up cadence. That is a project, not an afternoon.
A referral path lets a practice answer the question well without taking the project on.
What sits where
- Your practice: the ongoing relationship, primary care, and the introduction.
- Baseline: consult, intake, education, protocol coordination, dispensary setup, and the check-in schedule.
- Licensed provider network: medical review and prescribing.
- Compounding pharmacies: 503A or 503B fulfillment when appropriate.
What you still see
Referral without visibility is just a handoff. With the patient's consent, partner practices are kept in the loop on what their patient was reviewed for, what they were placed on, and when the next review lands.
What this means for you
If patients are asking and the answer is currently 'that's not something we do,' a referral pathway changes the answer without changing your operations.